VBI Vaccines
Stock Forecast, Prediction & Price Target
VBI Vaccines Financial Estimates
VBI Vaccines Revenue Estimates
VBI Vaccines EBITDA Estimates
VBI Vaccines Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $631K N/A | $1.08M 71.47% | $8.68M 702.40% | Avg: $34.12M Low: $34.12M High: $34.12M avg. 293.03% | Avg: $58.84M Low: $58.84M High: $58.84M avg. 72.43% | Avg: $96.53M Low: $96.53M High: $96.53M avg. 64.06% | Avg: $153.83M Low: $153.83M High: $153.83M avg. 59.35% |
Net Income
% change YoY
| $-72.65M N/A | $-140.95M -94.01% | $-92.83M 34.13% | Avg: $-14.80M Low: $-4.36M High: $-4.36M avg. 84.05% | Avg: $-14.00M Low: $-3.58M High: $-3.58M avg. 5.37% | Avg: $1.09M Low: $1.09M High: $1.09M avg. 107.78% | Avg: $6.22M Low: $6.22M High: $6.22M avg. 471.42% |
EBITDA
% change YoY
| $-68.03M N/A | $-81.82M -20.26% | $-53.32M 34.83% | Avg: $-34.12M Low: $-34.12M High: $-34.12M avg. 36.00% | Avg: $-58.84M Low: $-58.84M High: $-58.84M avg. -72.43% | Avg: $-96.53M Low: $-96.53M High: $-96.53M avg. -64.06% | Avg: $-153.83M Low: $-153.83M High: $-153.83M avg. -59.35% |
EPS
% change YoY
| -$8.55 N/A | -$16.37 -91.46% | -$5.96 63.59% | Avg: -$0.28 Low: -$0.28 High: -$0.28 avg. 95.30% | Avg: -$0.23 Low: -$0.23 High: -$0.23 avg. 17.85% | Avg: $0.07 Low: $0.07 High: $0.07 avg. 130.43% | Avg: $0.4 Low: $0.4 High: $0.4 avg. 471.42% |
Operating Expenses
% change YoY
| $57.89M N/A | $71.62M 23.72% | $49.49M -30.89% | Avg: $976.28M Low: $976.28M High: $976.28M avg. 1872.44% | Avg: $1.68B Low: $1.68B High: $1.68B avg. 72.43% | Avg: $2.76B Low: $2.76B High: $2.76B avg. 64.06% | Avg: $4.40B Low: $4.40B High: $4.40B avg. 59.35% |
FAQ
What is VBI Vaccines stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 167.16% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -4.36M, average is -14.80M and high is -4.36M.
What is VBI Vaccines stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 122.22% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $34.12M, average is $34.12M and high is $34.12M.
What is VBI Vaccines stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 178.75% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.28, average is -$0.28 and high is $-0.28.